Tripletail Wealth Management’s BriaCell Therapeutics BCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$128K Buy
+30,000
New +$111K 0.15% 109

Other funds holding BCTX

Tripletail Wealth Management's BCTX Position: Q3 2026 in Review

Tripletail Wealth Management opened a new position in BriaCell Therapeutics (BCTX) in Q3 2026: 30,000 shares worth $128K. The stake represents 0.15% of the portfolio and ranks #109 among its holdings.

19 funds tracked by Wall St. Rank hold BCTX as of Q3 2026.

  • Tripletail Wealth Management held 30,000 shares of BriaCell Therapeutics worth $128K as of Q3 2026.
  • BriaCell Therapeutics was a new Tripletail Wealth Management position in Q3 2026.
  • BriaCell Therapeutics made up 0.15% of Tripletail Wealth Management's portfolio in Q3 2026, its #109 holding.
  • 19 funds tracked by Wall St. Rank held BriaCell Therapeutics as of Q3 2026.

Based on Tripletail Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.